BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Milani L, Galindo CM, Turin de Oliveira NM, Corso CR, Adami ER, Stipp MC, Beltrame OC, Acco A. The GLP-1 analog liraglutide attenuates acute liver injury in mice. Ann Hepatol 2019;18:918-28. [PMID: 31151874 DOI: 10.1016/j.aohep.2019.04.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Manchanda Y, Bitsi S, Kang Y, Jones B, Tomas A. Spatiotemporal control of GLP-1 receptor activity. Current Opinion in Endocrine and Metabolic Research 2021;16:19-27. [DOI: 10.1016/j.coemr.2020.07.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
2 Wu YR, Shi XY, Ma CY, Zhang Y, Xu RX, Li JJ. Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway. Cardiovasc Diabetol 2019;18:146. [PMID: 31706303 DOI: 10.1186/s12933-019-0954-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
3 Iskusnykh IY, Kryl'skii ED, Brazhnikova DA, Popova TN, Shikhaliev KS, Shulgin KK, Matasova LV, Popov SS, Zhaglin DA, Zakharova AA, Popova NR, Fattakhov N. Novel Antioxidant, Deethylated Ethoxyquin, Protects against Carbon Tetrachloride Induced Hepatotoxicity in Rats by Inhibiting NLRP3 Inflammasome Activation and Apoptosis. Antioxidants (Basel) 2021;10:122. [PMID: 33467773 DOI: 10.3390/antiox10010122] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Fei Y, Tsoi MF, Cheung BMY. Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis. Cardiovasc Diabetol 2019;18:112. [PMID: 31462224 DOI: 10.1186/s12933-019-0916-z] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 25.5] [Reference Citation Analysis]